@article{0e373a5e3331452093247d5255bad097,
title = "Revealing KRas4b topology on the membrane surface",
abstract = "KRas4b is a membrane-bound regulatory protein belonging to the family of small GTPases that function as a molecular switch, facilitating signal transduction from activated membrane receptors to intracellular pathways controlling cell growth and proliferation. Oncogenic mutations locking KRas4b in the active GTP state are responsible for nearly 85% of all Ras-driven cancers. Understanding the membrane-bound state of KRas4b is crucial for designing new therapeutic approaches targeting oncogenic KRas-driven signaling pathways. Extensive research demonstrates the significant involvement of the membrane bilayer in Ras-effector interactions, with anionic lipids playing a critical role in determining protein conformations The preferred topology of KRas4b for interacting with signaling partners has been a long-time question. Computational studies suggest a membrane-proximal conformation, while other biophysical methods like neutron reflectivity propose a membrane-distal conformation. To address these gaps, we employed FRET measurements to investigate the conformation of KRas4b. Using fully post-translationally modified KRas4b, we designed a Nanodisc based FRET assay to study KRas4b-membrane interactions. We suggest an extended conformation of KRas4b relative to the membrane surface. Measurement of FRET donor - acceptor distances reveal that a negatively charged membrane surface weakly favors closer association with the membrane surface. Our findings provide insights into the role of anionic lipids in determining the dynamic conformations of KRas4b and shed light on the predominant conformation of its topology on lipid headgroups.",
keywords = "Cancer signaling, KRas4b, Lipid specificity, Membrane topology, Nanodisc",
author = "Shweta Shree and McLean, {Mark A.} and Stephen, {Andrew G.} and Sligar, {Stephen G.}",
note = "We thank Dr. Ilia Denisov and Dr. Yelena Grinkova from the University of Illinois at Urbana-Champaign for helping with MATLAB modeling, numerous insightful discussions, and helpful suggestions. We express gratitude to the Gorfe Group for their generous provision of the OS1 and OS2 PDB coordinates and Dr. Rebika Shrestha for her advise on labeling KRas-FME. We gratefully acknowledge the support of a MIRA grant from the National Institutes of Health (R35 GM118145) for funding this research. This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. 75N91019D00024. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the U.S. Government. We extend special thanks to the NCI RAS Initiative at the Frederick National Laboratory for Cancer Research, led by Dr. Frank McCormick and Dr. Dwight Nissley, and their team members for their valuable collaboration. We also thank Vanessa Wall, Kelly Snead, Shelley Perkins, William K Gillette and Dominic Esposito for production of the KRas4b protein used in this work. Finally, we thank Dana Rabara for performing the Phosphate senor assays on the KRas4b proteins. We thank Dr. Ilia Denisov and Dr. Yelena Grinkova from the University of Illinois at Urbana-Champaign for helping with MATLAB modeling, numerous insightful discussions, and helpful suggestions. We express gratitude to the Gorfe Group for their generous provision of the OS1 and OS2 PDB coordinates and Dr. Rebika Shrestha for her advise on labeling KRas-FME. We gratefully acknowledge the support of a MIRA grant from the National Institutes of Health ( R35 GM118145 ) for funding this research. This project has been funded in whole or in part with Federal funds from the National Cancer Institute, National Institutes of Health , under Contract No. 75N91019D00024 . The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products or organizations imply endorsement by the U.S. Government. We extend special thanks to the NCI RAS Initiative at the Frederick National Laboratory for Cancer Research, led by Dr. Frank McCormick and Dr. Dwight Nissley, and their team members for their valuable collaboration. We also thank Vanessa Wall, Kelly Snead, Shelley Perkins, William K Gillette and Dominic Esposito for production of the KRas4b protein used in this work. Finally, we thank Dana Rabara for performing the Phosphate senor assays on the KRas4b proteins.",
year = "2023",
month = oct,
day = "20",
doi = "10.1016/j.bbrc.2023.08.035",
language = "English (US)",
volume = "678",
pages = "122--127",
journal = "Biochemical and Biophysical Research Communications",
issn = "0006-291X",
publisher = "Elsevier B.V.",
}